Voyager Therapeutics to Present at the Jefferies Healthcare Conference
CAMBRIDGE, Mass., June 01, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced that CEO Alfred W. Sandrock, Jr., M.D., Ph.D., will present at the Jefferies Healthcare Conference on Thursday, June 8, 2023, at 3:30 p.m. ET.
A webcast of the presentation may be accessed from the Investors section of Voyager’s website at www.voyagertherapeutics.com. A replay of the webcast will be archived on the Company's website for at least 30 days.
About Voyager Therapeutics
Voyager Therapeutics® is a registered trademark, and TRACER™ is a trademark, of Voyager Therapeutics, Inc.
Making an Educated Decision about Connectivity
Keynote Panel: The Continued Rise of AI: Embracing the Known and Unknown to Drive Business Results
Continental Breakfast Served